Patrick M Vanderboom
Overview
Explore the profile of Patrick M Vanderboom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
498
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vanderboom P, Chawla Y, Dasari S, Kapoor I, Kumar S, Nair K, et al.
Eur J Haematol
. 2024 May;
113(3):351-356.
PMID: 38804098
Background: Precursor plasma cell disorders such as monoclonal gammopathy of undetermined significance (MGUS) always precede the development of active malignancies such as multiple myeloma (MM). There is a need for...
2.
Vanderboom P, Misra A, Rodino K, Eberly A, Greenwood J, Morris H, et al.
Am J Clin Pathol
. 2023 Dec;
161(5):451-462.
PMID: 38113371
Objectives: Recent work has demonstrated that automated fluorescence flow cytometry (FLC) is a potential alternative for the detection and quantification of Plasmodium parasites. The objective of this study was to...
3.
Marcotte G, Miller M, Kunz H, Ryan Z, Strub M, Vanderboom P, et al.
JCI Insight
. 2023 Oct;
8(22).
PMID: 37815864
Aging and many illnesses and injuries impair skeletal muscle mass and function, but the molecular mechanisms are not well understood. To better understand the mechanisms, we generated and studied transgenic...
4.
Vanderboom P, Renuse S, Maus A, Madugundu A, Kemp J, Gurtner K, et al.
J Proteome Res
. 2022 Jul;
21(8):2045-2054.
PMID: 35849720
Targeted mass spectrometry-based platforms have become a valuable tool for the sensitive and specific detection of protein biomarkers in clinical and research settings. Traditionally, developing a targeted assay for peptide...
5.
Renuse S, Benson L, Vanderboom P, Ruchi F, Yadav Y, Johnson K, et al.
Clin Proteomics
. 2022 May;
19(1):16.
PMID: 35590248
Background: Glucagon serves as an important regulatory hormone for regulating blood glucose concentration with tight feedback control exerted by insulin and glucose. There are critical gaps in our understanding of...
6.
Mangalaparthi K, Chavan S, Madugundu A, Renuse S, Vanderboom P, Maus A, et al.
Clin Proteomics
. 2022 May;
19(1):11.
PMID: 35508993
No abstract available.
7.
Nakao Y, Fukushima M, Mauer A, Liao C, Ferris A, Dasgupta D, et al.
Front Cell Dev Biol
. 2021 Nov;
9:735001.
PMID: 34805145
Extracellular vesicles (EVs) are emerging mediators of intercellular communication in nonalcoholic steatohepatitis (NASH). Palmitate, a lipotoxic saturated fatty acid, activates hepatocellular endoplasmic reticulum stress, which has been demonstrated to be...
8.
Maus A, Renuse S, Kemp J, Madugundu A, Vanderboom P, Blommel J, et al.
J Proteome Res
. 2021 Nov;
21(1):142-150.
PMID: 34779632
COVID-19 vaccines are becoming more widely available, but accurate and rapid testing remains a crucial tool for slowing the spread of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus. Although...
9.
Mangalaparthi K, Chavan S, Madugundu A, Renuse S, Vanderboom P, Maus A, et al.
Clin Proteomics
. 2021 Oct;
18(1):25.
PMID: 34686148
SARS-CoV-2, a novel human coronavirus, has created a global disease burden infecting > 100 million humans in just over a year. RT-PCR is currently the predominant method of diagnosing this...
10.
Vanderboom P, Mun D, Madugundu A, Mangalaparthi K, Saraswat M, Garapati K, et al.
Mol Cell Proteomics
. 2021 Aug;
20:100134.
PMID: 34400346
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, has become a global health pandemic. COVID-19 severity ranges from an asymptomatic infection to a severe...